دکتر مسعود قاسمی

Personal Information

  • Name: Massoud Ghasemi
  • Date of Birth: 26.02.1960
  • Email: ghasemi@iranathero.ir
  • Mailing Address: No 9, No 45, the corner of Hafezi St, Derakhti St, Dadman Boulevard, Shahrak Gharb, Tehran, Iran. Postal code: 1981617995
  • Telephones: +98 21 22387706, +989121088865

 

Interventional Cardiology Profession

Recent Positions:

  • Chairman of Iranian Society of Atherosclerosis.
  • Consultant in Cardiology,Interventional Cardiologist, AttendingCardiologist,Imam Khomeini MedicalCenter, Tehran Universityof MedicalSciences. Tehran,Iran.
  • Director, Research Center ofEndovascularIntervention & President ofInternational Meetingof Cardiovascular Update.
  • Director, CardiacCatheterization andInterventional Cardiology, PayambaranHospital. Tehran,Iran.
  • Director, CardiacCatheterization andInterventional Cardiology, Laleh  Hospital. Tehran,Iran.
  • Director, CardiacCatheterization andInterventional Cardiology, Sasan Hospital. Tehran
  • Interventional Cardiologist of Pars Hospital. Tehran,Iran. Chairman of AryaAtherosclerosisJournal
  • ExecutiveDirector ofEndovascularJournal (official Journal of
  • Research Centerof EndovascularIntervention)
  • Head of scientific committee, BAM Riding school
  • Director, Cardiac Catheterization and Interventional Cardiology, Bahman Hospital. Tehran
  • Iran's representative in WHO for non-communicable diseases (Influenza prevention in high risk population)

 

Scientific/ManagerialActivities:

  • President of theInternationalCongress of CardiovascularUpdates, 2004- Current
  • Fellow of Tehran University of Medical Sciences, 1992-Current 
  • Dyslipidemia Advisory board, Feb 2017, Amgen, Tehran, Iran.
  • Hypertension Advisory board; Novartis, Nov, 2017, Tehran, Iran
  • FOURIER Advisory Board; Amgen, Dec 2017, Tehran , Iran.
  • Cardiology Advisory board, MERCK, Dec 2017, Rome, Italy.   
  • President, Heart &New TechnologyMeeting(February28- March3rd,2006 Ramsar)
  • Memberofscientificcommitteeof TheFirst Congress of CardiovascularUpdate (1998-2003, Tehran)
  • VicePresident ofthe Fifth Congress of CardiovascularUpdates (June2004, Tehran) 
  • Activemember infundament ofthe first cardiovascular researchanimal laboratoryin Tehran University
  • President of firstsymposiumin stem celland cardiovascular Disease

ProfessionalMemberships:

  • International Associate of American College of Cardiology
  • New YorkAcademyof Science
  • InternationalAssociate of American Collegeof Cardiology
  • European Atherosclerosis Association
  •  International SocietyofEndovascularSpecialists
  • Iranian Heart Association
  • Iranian SocietyofAtherosclerosis
  • Research Centerof EndovascularIntervention
  • Working grouponInterventional Cardiologyof theEuropeanSocietyof Cardiology

 

Education:

  • Doctorate of Medicine,Facultyof Medicine, TehranUniversity, Tehran,Iran. 1986

Residency& Postdoctoral Training:

  • Department of Cardiology,Facultyof Medicine, Tehran
  • University.Tehran,Iran. 1986-1991                  
  • Fellowship inInterventionalCardiology,Facultyof Medicine, Tehran University. Tehran,Iran. 1991-1992                  

 

Certifications and Trainings:

 

  • Minimalist TF - TAVI training seminar, By Prof Alain Cribier, 14 - 16 May 2017-Rouen ,France
  • Updates of TAVI training, George Pompidu Hospital, April 2017, Paris, France. 
  • Winner of theFirstPrize forthe "Most Educational Caseat theCIT 2006.
  • Certification ofEndovascularIntervention (Cerebrovascularand peripheral), Scripps Clinic,California, USA. 2003
  • Certification ofInterventional Cardiology, RoyalBrompton &  Harefield Hospital,London, 1996
  • Certification ofInterventional Cardiology,the Royal Marsden, 1994
  • NHSTrust,London.UK.c
  • Certification ofInterventional Cardiology,France, 1993

 

ResearchProjects&GrantsFunding:

 

  • Activeresearcher in surveyof stem celltransplantation for repair ofmyocardial infarction (April 2004-Current)
  • Activeresearcher in surveyof detection ofmutations in patients with hypertrophic cardiomyopathy
  • Researcher of foundation ofthe stem cellpreparation laboratoryin Sasan Hospital
  • Main investigator: Registry of assessment of PCI use in STEMI and NSTEMI patients in Iran , 2017
  • Main investigator in Persian Driver Registry(2004-2005)
  • MainInvestigator in theFamilyof Endeavor Persian Registry-FAVORI&II(2005-2008)
  • MainInvestigator in theXienceV Persian Registry(2007-2008)

 

ScientificAndProfessionalPublications:

- Thesis:

  • Structural Heart Diseases Based on Congenital Heart Diseases (in referral patients to Tehran university hospital) . MD Degree, Tehran University, Iran.1986
  • Midterm results of PTCA compared tocoronaryarterybypass graftandmedical treatment. FellowshipDissertation, TehranUniversity,Tehran,Iran.1992.

 

- Published papers:

  • M. Ghasemi: Resultsof new method (MGH)inPhrenic nerve. Tehran, Journalof Facultyof Medicine, 1987.
  • M. Ghasemi:Results of catheterism in congenital heartdisease. Tehran, Journal of Faculty of Medicine, 1987.
  • M. Ghasemi:Hydaticcyst in the heart. Journal of Medical CouncilofIslamic republicofIran, 1992.
  • M. Ghasemi:Prevention of hypertension. Tehran, Journalof basic scienceofIran, 1992.
  • M. Ghasemi:Atherosclerosisof coronaryartery. Tehran,JournalofBasic ScienceofIran,1992.
  • M. Ghasemi:Role ofX-rayin diagnosis ofcardiovasculardisease. Tehran, Journal ofBasic ScienceofIran, 1993.
  • M. Ghasemi:Technologyin medicine. Tehran,JournalofBasic ScienceofIran,1993.
  • M. Ghasemi:Anemiaand hydatid cyst of the heart.Tehran,Iranian ACTAMedical Journal,1992.
  • M. Ghasemi:ATPand the heart.Tehran,Iranian ACTA Medical Journal, 1989.
  • M. Ghasemi:Results of Mitral valvevalvaloplasty.Tehran,Journal of Medical Councilof Islamic Republic ofIran,1996.
  • M. Ghasemi:Incidenceof infectiveendocarditis caused bydentistry. Tehran,Journal of AzadIslamic, 2000.
  • M. Ghasemi:Analysisof theabundanceof heart typesthroughout angioplasty. Tehran,Journal ofIranUniversity,2000.
  • M. Ghasemi:Angioplastyand the types of disease. Tehran,Journal ofIranUniversity,2000.
  • M. Essalat, S.H.Mirkhani,M.Ghasemi, M.Sanatkar, R.Zarezadeh: Atherosclerosisof theinternal mammaryarteryinpatients undergoingcoronaryartery bypassgrafting.Tehran,IranianACTA Medica Journal,Vol 14, No 3, 2003, pp 188-193.
  • M.  Ghasemi,  N.Naderi,  M.  Sanatkar:  Effects  ofintravenous  immunoglobulin treatmenton patients with chronic heartfailure,Delhi, IndianHeartJournal, 2004.
  • M.Ghasemi,E.Nematipour,N.Naderi,M.Sanatkar:Safetyandefficacyofredo percutaneousMitral valvuloplasty(PMV).Delhi, IndianHeartJournal, 2004.
  • M.Ghasemi,M.Sanatkar:TheArterialStiffnessIndex(ASI)andriskofrestenosis. Tehran,IranianHeartJournal, 2004.
  • M.  Ghasemi,  Hashemi  Fesharaki,  M.  Sanatkar:  Basilar artery angioplastyand stenting.EuropeanJournal of Vascularand EndovascularSurgery,2006.
  • ArashMohammadiTofigh,M Ghasemi,BabakHeidariAghdam,Mersedeh Karvandi ,AfsoonKaboli:Endovasculartreatmentofthoracoabdominalaortic aneurysm:acasereport.JournalofMedicalCaseReports,2010.
  • M.Ghasemi, P.Ghazi, M.Zarghampour, A.Haji-zeinali : Transcatheter stent implantation for the treatment of abdominal Aortic Coarctation and right renal artery stenosis in Takayasu`s arteries ; A case with a 4 years follow up. Hellenic Journal of cardiology, 2011
  • M.Ghasemi: One –stage angioplasty and stenting of ostium of left common carotid artery and stenting of left internal carotid artery in an 81-years-old man with transient ischemic attackActa Medica Iranica, Vol. 55, No. 1،2017
  • M.Ghasemi : Autologous Adult Stem Cell Transfusion In Chronic Revascularized Patients Including Post PCI and Post CABG Conditions – 2015
  • M.Ghasemi , M Mehrpoya: Redo percutaneous mitral valvuloplasty (Redo PMV) in patients with recurrent mitral valve stenosis: Immediate and early outcomes
  • M.Ghasemi :Sense of impending doom during angioplasty for patients also interventionists, 2017

 

Presentations/Invitational Lectures:

 

  • IranianHeart Association, Pulmonaryvalvuloplasty & Results of coronaryarteryangioplasty. 1992
  • Meeting ofRehabilitation, 1992: New methods in treatment of
  • IranianInternist Association, 1992: Results of balloon dilatation of pulmonary valve stenosis.
  • SymposiumofHeartDisease, 1993: EchocardiographyinHeart Disease.
  • Symposiumofheartdisease, 1993: Heart Valvualr Disease.
  • IranianHeart Association, 1993: Hemodynamic effects of Mitral Valvuloplasty.
  • IranianHeart Association, 1993: CombinedMitral and Tricuspid valve commisurotomy.      
  • IranianHeart Association, 1993: Effectsof contrast substitute in
  • IranianHeart Association, 1993: Descriptive studyof anatomopathologic
  • Variable inIranian population.
  • IranianHeart Association, 1993: Report of Mitral valvevalvuloplastyin Angioplastyof coronaryartery 470cases
  • IranianHeart Association, 1993: Comparisonof Mitral Regurgitation preand Post-valvuloplasty.
  • Cardiovascular Meeting, Shiraz-Iran, 1998: Treatmentofin-stentrestenosis with Balloon dilatation.
  • Cardiovascular Meeting, Shiraz-Iran, 1998: Drugelutingstents.
  • Cardiovascular Meeting, Shiraz-Iran, 1998: Resultsof stentingin coronaryartery disease.
  • ShirazCongress ofCardiovascular Disease, 2000: Curingthe stenosis inside a stent usingangioplastyballoon.
  • ShirazCongress ofCardiovascular Disease, 2000: Whystent?
  • 12th Congress ofCardiology inTehran, 2001:Initialstentingin coronarystenosis.
  • 13th Congress ofIranianHeart Association, 2003, Tehran: Stem cell transplantation in patients with previous myocardial infarction.
  • ICCAjman, March2004: Angioplastyand stentingfor symptomatic basilar artery stenosis.
  • ICCAjman, March2004: Percutaneous internal carotid arteryangioplastywith stenting.
  • ICCAjman, March2004: Drug-Elutingstents fortreatment of patients with atheroscleroticlesions in coronaryarteries, doubleblind, randomized controlled trial.
  • GulfHeart Association,January, 2004, Muscat, Oman: Safetyandefficacyofredo percutaneous Mitral Valvuloplasty.
  • GulfHeart Association,, Muscat, Oman: PosterPresentation: Immunomodulatingtherapywith intravenous immunoglobulin in patients with chronic heart failure.January, 2004
  • Cardio-health Symposium, July, 2004,Istanbul, Turkey:Acutecoronary syndromes: Update and new trends.
  • Cardio-health Symposium, July, 2004,Istanbul, Turkey:Percutaneous coronary interventions.
  • Chairman, 6th International Congress onCardiovascular Update, June, 2004, Mashad –Iran:Noninvasive coronaryangiographywith spiral CT.
  • Chairman, 6th International Congress onCardiovascular Update, June, 2004, Mashad –Iran: Percutaneousextracranial arteryangioplasty.
  • InvitedFaculty/GuestLecturer, 7thAsianPacific BiennialConference, December 2004
  • Islamabad, Pakistan:Stateof theart lecture,Mitral valverestenosismanagement.
  • Guest Faculty, JointInterventional Meeting, February2005, Rome,Italy: Vetebrobasilar ArteryStenting(CaseReport).
  • InvitedFaculty/GuestLecturer,2ndWorldCongress ofInternationalCardiology, February, 2005, Mumbai: Angioplasty&Stenting in symptomatic basilar ArteryStenosis.
  • InvitedGuestpanelist/livecasePresentation,2ndWorldCongress of
  • International Cardiology, February, 2005, RubyHallClinic, Pune,India.
  • Guest faculty, EUROPCR2005, May2005,Paris: Peripheral Clinical Case Presentation;VetebrobasilarArteryStenting.
  • IranianSociety ofAtherosclerosis, third Seminar on Complicated Carotid Intervention, July2005,Tehran:Bilateral Carotid Angioplasty.
  • GuestFaculty/CasePresentation,China Interventional Therapeutics (CIT) 2006 in Conjunction with TCTat CITandEuroPCRat CITApril6-9, 2006.
  • Beijing International ConventionCenter, China: 1)AcuteTotal Occlusion oftheLeft MainArteryduringCoronaryAngiographyResultin CardiacArrest& Its Management;2) Crush Aorto-Renal Stenting; 3) Vertebro-Subclavian Stenting.
  • GuestFaculty/CasePresentation,Angioplasty Summit 2006-TCT Asia–Pacific,
  • Acute Total Occlusion oftheLeft Main Arteryduring,26-28 April, 2006 in Seoul-Korea:
  • CoronaryAngiographyResultin CardiacArrest &Its Management.
  • PosterPresentation,"WorldCongress ofCardiology"2006-Barcelona:Repeat Percutaneous Mitral Valvuloplasty(PMV)
  • InternationalGuestfaculty/GuestLecturer,"2ndInternational ConferenceofNewer Frontiers inCardiology–Mumbai Hospital",2006,India:EndeavorExperience,2) PCIafter Thrombolysis: For Whom and When?3) Role ofMSCT 64 in CAD
  • GuestLecturer, 16thAsianPacific CongressofCardiology, Dec.13-16, 2007, Taipei, Taiwan: “Repeat Percutaneous Mitral Valvuloplasty(PMV)in Patients with Restenosis followingto previous PMV”.
  • GuestLecturer, JointInterventional Meeting, February2008, Rome,Italy: Urgent Carotid arteryangioplastyand stentingwith distalembolic protection in acute stroke (CaseReport).
  • Guest faculty, EUROPCRp;, May2008Barcelona-Spain: Pulmonaryarteryangioplastyand stenting followinganastomoticpulmonaryhypertension after lungtransplantation for idiopathic pulmonaryfibrosis.
  • PosterPresentation, 14th WorldCongressonHEART DISEASE,July2008, Toronto -Canada:Prevalenceand predictors ofrenal arterystenosis in patients undergoingcoronaryangiography.
  • Posterpresentation,Canadian cardiovascularCongress, October 2009Repeat percutaneous mitralValvuloplastyin patients with recurrent mitral valve stenosis following to previous PMV
  • Oral Presentation,15th WorldCongress onHEART DISEASE, July2010, Vancouver–Canada: Repeat Percutaneous MitralValvuloplasty(PMV)In Patients with Recurrent Mitral ValveStenosis FollowingTo Previous PMV
  • Oral Presentation, CanadianCardiology Congress, October2010, Montreal- Quebec: Urgent Carotidarteryangioplastyand stentingwith distal embolic protection in acute stroke(CaseReport).
  • Oral presentation, Canadian Cardiovascularcongress, October 2011, Pulmonaryarteryangioplastyand stentingfollowinganastomoticpulmonary hypertension after lungtransplantationforidiopathic pulmonaryfibrosis
  • Percutaneous aortic valve implantation of core valve; first case report in Iran , PCR London valve, 2011.
  • Challenging coronary artery intervention ,How would I treat? Euro PCR 2012
  • Complex coronary PCI involving the left anterior descending, circumflex first and second obtuse marginal ; Euro PCR 2013
  •  ESC guideline updates in ACS management , 2nd Atherothrombosis day ; Iran 2014
  • M.Ghasemi: New intervention Technology in treatment of Cerebro-vascular disease ,First congress on Novel Approaches of biomedical engineering in cardiovascular disease; Iran
  • Clinical aspect & hyperlipidemia guideline ,Hyperlipidemia from A to Z ; Iran 2015
  • Chairperson of Heart Failure Symposium (Sponsored by Novartis), Tehran, Iran, 2016
  • Lecture on Secondary Hypertension (Sponsored by Abidi), Tehran, Iran, 2016
  • Invited Speaker in 1st Caspian Annual meeting about 1)TAVI and Valves 2)A challenging case in coarctation, Mashhad, 2017
  • Invited guest; 33rd Turkish Cardiology Congress, Oct. 2017
  • Invited Speaker, Multidisciplinary approach to NOACs, Feb 15th 2018, Tehran,Iran.

 

REFERENCES:

  • DrCharles D.J. Ilsey. Director ofcardiology, Harefield Hospital.

Hill End Road, Middlesex, UB9 6JH, London.UK.

  • Dr. A. Mitchell.Consultant cardiologist, Harefield Hospital. HillEnd Road, Middlesex, UB96JH, London.UK.
  • Dr. V.Paul.Consultant cardiologist, Harefield Hospital. HillEnd Road, Middlesex, UB9 6JH, London.UK.
  • Dr B. Valeix.Ancienassistant deshôspital. Chef declinique cardiologiquealafaculté médicine des hospital, France.
  • M. Saeed. Head,Division of Vascular Radiology.Scripps clinic,LaJolla, California, USA.
  • Dr.Paul S.Teirstein.Head, Department of Cardiology.Scripps clinic,La Jolla, California, USA.

 

***To download the complete Resume please click on the link below:

 

جستجو

+